ANN ARBOR STAGE IV HODGKIN LYMPHOMA
Clinical trials for ANN ARBOR STAGE IV HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE IV HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE IV HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to control advanced blood cancer: two promising drug combinations face off
Disease control OngoingThis large Phase 3 trial aims to find the better treatment combination for newly diagnosed advanced Hodgkin lymphoma. It compares adding either nivolumab or brentuximab vedotin to standard chemotherapy. The study will measure which combination keeps the cancer from returning long…
Matched conditions: ANN ARBOR STAGE IV HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug combo offers hope for older hodgkin lymphoma patients unsuitable for standard chemo
Disease control OngoingThis study is testing a combination of two immunotherapy drugs, nivolumab and brentuximab vedotin, for older adults or those who cannot tolerate standard chemotherapy for untreated Hodgkin lymphoma. The goal is to see how well this drug combination controls the cancer by helping …
Matched conditions: ANN ARBOR STAGE IV HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC